Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
Abroad (travel likely)RecruitingPHASE3
Conditions
Acquired Fibrinogen Deficiency
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom
Contact: Study coordinator (Asoke Roy)
Study leads
Study Director
CSL Behring